ArticleBlood2026

Ramantamig (JNJ-79635322), a novel T-cell-engaging trispecific antibody targeting BCMA, GPRC5D, and CD3, in multiple myeloma models.

Kodandaram Pillarisetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.